Net Margin - Molecular Partners AG (NASDAQ:MOLN) - Alpha Spread

Molecular Partners AG
NASDAQ:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
NASDAQ:MOLN
Watchlist
Price: 4.67 USD -3.51% Market Closed
Market Cap: 155m USD
Have any thoughts about
Molecular Partners AG?
Write Note

Net Margin
Molecular Partners AG

-663.9%
Current
-451%
Average
-7.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-663.9%
=
Net Income
-69.1m
/
Revenue
10.4m

Net Margin Across Competitors

Country CH
Market Cap 155m USD
Net Margin
-664%
Country US
Market Cap 341.9B USD
Net Margin
10%
Country US
Market Cap 180.5B USD
Net Margin
10%
Country US
Market Cap 129B USD
Net Margin
32%
Country US
Market Cap 123.6B USD
Net Margin
-5%
Country US
Market Cap 104.5B USD
Net Margin
4%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 142.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.4B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for Molecular Partners AG.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-663.9%
=
Net Income
-69.1m
/
Revenue
10.4m
What is the Net Margin of Molecular Partners AG?

Based on Molecular Partners AG's most recent financial statements, the company has Net Margin of -663.9%.